Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PYNNACLE: Rezatapopt in TP53 Y220C Mutated Solid Tumors
NCT04585750Phase 2Recruiting
- Sponsor
- PMV Pharmaceuticals, Inc.
- Start
- Oct 2020
- Primary completion
- Dec 2026
- Countries
- 9
01
Overview
A Phase 2 trial of rezatapopt in solid tumor, sponsored by PMV Pharmaceuticals, Inc.. Started Oct 2020; status: recruiting.
02
Drugs
rezatapopt
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04585750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04585750.